Cisplatin

CD24 molecule ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34293822 The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas. 2022 Feb 4
2 33919109 Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44+CD24- Sorted MDA-MB-231 Cells by Cisplatin. 2021 Apr 21 1
3 34076552 Identification of Chemo and Radio-Resistant Sub-Population of Stem Cells in Human Cervical Cancer HeLa Cells. 2021 Sep 1
4 34123574 Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness. 2021 Jun 1 1
5 31904742 Phenotypic and microRNA characterization of the neglected CD24+ cell population in MCF-7 breast cancer 3-dimensional spheroid culture. 2020 Jan 1
6 32194682 Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer. 2020 Mar 2
7 28179302 CD24 Modulates Chemosensitivity of MCF-7 Breast Cancer Cells. 2017 Feb 1
8 28440503 CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways. 2017 Jun 2
9 27276062 CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma. 2016 4
10 27924308 pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma. 2016 Nov 23 1
11 25736055 BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer. 2015 May 1
12 24612587 Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma. 2014 Mar 11 1
13 22995296 Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells. 2012 Oct 19 1
14 21726833 CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. 2011 Jul 8 1
15 16092668 Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients. 2005 1